Commentary & Perspectives

Why Copilots Failed in R&D and What Comes Next 

Organizations that benefit most from AI in R&D will be those that align technology with scientific reality

Share

  • 1

    Generative AI's potential in R&D is underutilized.

  • 2

    Early AI tools neglected scientific standards.

  • 3

    Current tools must ensure transparency and trust.

  • 4

    Researchers need to define workflows where AI is integrated.

  • 5

    The focus should switch from productivity to evidence-based decisions.

  • 6

    Agentic AI can effectively coordinate certain tasks.

  • 7

    Expect gradual progress in aligning AI with complex scientific workflows.

  • 8

    Future effectiveness hinges on technology meeting rigorous scientific requirements.

Original Source(s)

Why Copilots Failed in R&D and What Comes Next 

  • by Yiannis Kiachopoulos

  • March 16, 2026

Related Content

RSV Vaccine Eligibility Expands

Trial data show noninferior immune response in high-risk adults aged 18 to 49 years.

Clinicians Warn of Fatal Measles Brain Disease

Doctors caution that measles infection can lead to SSPE, a rare fatal neurologic disease that may appear years later.

The New Blueprint for Vaccine Development

ReiThera’s leaders discuss platform technologies, scalable manufacturing, and the trust needed to strengthen global vaccine preparedness

  • March 12, 2026

  • 6 min